By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Genflow Biosciences plc

Genflow Biosciences plc (GENF.L)

LSE Currency in GBP
£0.70
+£0.03
+5.11%
Last Update: 17 Jul 2025, 07:42
£3.17M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£0.65 - £2.40
52 Week Range

GENF.L Stock Price Chart

Explore Genflow Biosciences plc interactive price chart. Choose custom timeframes to analyze GENF.L price movements and trends.

There is nothing to show.

GENF.L Company Profile

Discover essential business fundamentals and corporate details for Genflow Biosciences plc (GENF.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

17 Jan 2022

Employees

5.00

CEO

Eric Jean Leire MBA

Description

Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.

GENF.L Financial Timeline

Browse a chronological timeline of Genflow Biosciences plc corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 1 May 2025

Earnings released on 7 May 2024

Earnings released on 7 May 2024

EPS came in at -£0.00, while revenue for the quarter reached -£97.03K.

Earnings released on 29 Sept 2023

EPS came in at -£0.00, while revenue for the quarter reached -£97.03K.

Earnings released on 30 Jun 2023

EPS came in at -£0.00, while revenue for the quarter reached £97.03K.

Earnings released on 31 Mar 2023

EPS came in at -£0.00, while revenue for the quarter reached £97.03K.

Earnings released on 31 Dec 2022

EPS came in at -£0.00.

Earnings released on 30 Sept 2022

EPS came in at -£0.00.

Earnings released on 30 Jun 2022

EPS came in at -£0.00.

Earnings released on 31 Mar 2022

EPS came in at -£0.00.

Earnings released on 30 Jun 2021

EPS came in at -£0.00.

Earnings released on 31 Mar 2021

EPS came in at -£0.00.

GENF.L Stock Performance

Access detailed GENF.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
GENF.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
GENF.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More